Table 1 Clinical and metabolic characteristics of subjects at baseline and 3 months post LSG

Age(years)

42. 71 ± 14.13

–

29.04 ± 5.85^**

–

Gender(Male/Female)

6/8

–

12/11

–

AN Score

–

–

3.52 ± 0.79

1.48 ± 0.73^##

BMI(kg/m²)

37.79 ± 4.87

30.57 ± 4.53^##

40.56 ± 4.54

31.92 ± 4.21^##

NC(cm)

43.64 ± 3.78

38.50 ± 3.21^##

44.89 ± 4.71

40.59 ± 3.47^##

WC(cm)

119.50 ± 13.93

102.14 ± 12.98^##

120.76 ± 11.07

102.78 ± 11.13^##

HC(cm)

122.07 ± 12.33

107.75 ± 10.23^##

122.43 ± 8.28

109.11 ± 9.13

WHR

0.98 ± 0.07

0.95 ± 0.07

0.99 ± 0.07

0.94 ± 0.07^##

FPG(mmol/L)

7.52 ± 3.23

5.45 ± 1.61^##

5.81 ± 1.62

4.53 ± 0.44^##

FINS(mmol/L)

23.24 ± 8.52

10.68 ± 5.17^##

44.81 ± 33.63^**

12.53 ± 7.90^##

FCP(mmol/L)

3.49 ± 1.15

2.47 ± 0.65^##

5.18 ± 2.10^**

2.75 ± 0.83^##

HOMA-IR

8.04 ± 3.73

2.59 ± 1.64^##

12.29 ± 10.94

2.57 ± 1.77^##

LNIR

1.98 ± 0.50

0.79 ± 0.58^##

2.22 ± 0.73

0.76 ± 0.63^##

HbA1c(%)

6.99 ± 1.84

5.79 ± 1.06^#

6.40 ± 1.18

5.21 ± 0.28^##

TC(mmol/L)

4.60 ± 1.17

4.23 ± 0.96

4.58 ± 1.12

4.41 ± 0.79

TG(mmol/L)

1.74 ± 0.66

1.17 ± 0.40^##

1.92 ± 1.62

1.14 ± 0.30^#

HDL(mmol/L)

1.04 ± 0.19

1.10 ± 0.28

0.94 ± 0.23

0.99 ± 0.22

LDL(mmol/L)

2.91 ± 0.97

2.57 ± 0.75^#

2.81 ± 0.86

2.84 ± 0.57